Waiting
Elaborazione accesso...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Brug RNA-sekventering til Detect Novel Splice…
JoVE Journal
Cancer Research

È necessario avere un abbonamento a JoVE per visualizzare questo Contenuto. Accedi o inizia la tua prova gratuita.

JoVE Journal Cancer Research
Brug RNA-sekventering til Detect Novel Splice Varianter Relateret til Drug Resistance i
 
Click here for the English version

Brug RNA-sekventering til Detect Novel Splice Varianter Relateret til Drug Resistance i

Article DOI: 10.3791/54714-v • 09:58 min • December 9th, 2016
December 9th, 2016 •
1,2,3, 1, 4, 3, 5, 6, 1,7, *1, *3,8,9
1Department of Pediatric Oncology/Hematology, VU University Medical Center, 2Department of Hematology, VU University Medical Center, 3Department of Medical Oncology, VU University Medical Center, 4Department of Clinical Genetics, VU University Medical Center, 5Division of General and Transplant Surgery, Azienda Ospedaliera Universitaria Pisana, Universita’ di Pisa, 6Amsterdam Immunology and Rheumatology Center, VU University Medical Center, 7Princess Máxima Center for Pediatric Oncology, 8Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, 9Institute of Nanoscience and Nanotechnology, CNR-Nano
* These authors contributed equally

Capitoli

Riepilogo
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Her beskriver vi en protokol til formål at undersøge effekten af ​​afvigende splejsning på resistens i solide tumorer og blodkræftsygdomme. Til dette mål, vi analyserede transkriptom profiler af forældrenes og resistente in vitro modeller gennem RNA-seq og etablerede et QRT-PCR-metode til at validere kandidatgener.

Tags

Cancer Research kemoterapi modstand cytotoksicitet alternativ splejsning RNA-seq transcriptomics
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter